Sana Biotechnology (SANA) Interest Expenses (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Interest Expenses data on file, last reported at $113.8 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 31.62% year-over-year to $113.8 million; the trailing twelve-month figure through Mar 2026 stood at $113.8 million (down 31.62% YoY), and the FY2025 full-year result was $119.3 million, up 53.81% from the prior year.
• Interest Expenses improved to $113.8 million in Q1 2026, from $1000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $402.7 million in Q4 2023 to a low of $1000.0 in Q4 2025.
• A 5-year average of $127.1 million and a median of $113.8 million in 2026 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses soared 10750.42% in 2023 and plunged 99.93% in 2025, its largest moves.
• Tracing SANA's Interest Expenses over 5 years: stood at $3.7 million in 2022, then soared by 10750.42% to $402.7 million in 2023, then tumbled by 99.63% to $1.5 million in 2024, then sank by 99.93% to $1000.0 in 2025, then surged by 11377100.0% to $113.8 million in 2026.
• Business Quant data shows SANA's Interest Expenses at $113.8 million in Q1 2026, $1000.0 in Q4 2025, and $42.6 million in Q3 2025.